Basically I just agree with what James said. But I think the steelman is something like: you should expect shorter (or no) pauses with an RSP if all goes well, because the precautions are matched to the risks. Like, the labs aim to develop safety measures which keep pace with the dangers introduced by scaling, and if they succeed at that, then they never have to pause. But even if they fail, they’re also expecting that building frontier models will help them solve alignment faster. I.e., either way the overall pause time would probably be shorter?
It does seem like in order to not have this complaint about the RSP, though, you need to expect that it’s shorter by a lot (like by many months or years). My guess is that the labs do believe this, although not for amazing reasons. Like, the answer which feels most “real” to me is that this complaint doesn’t apply to RSPs because the labs aren’t actually planning to do a meaningful pause.
In the previous RSP, I had the sense that Anthropic was attempting to draw red lines—points at which, if models passed certain evaluations, Anthropic committed to pause and develop new safeguards. That is,ifevaluations triggered,thenthey would implement safety measures. The “if” was already sketchy in the first RSP, as Anthropic was allowed to “determine whether the evaluation was overly conservative,” i.e., they were allowed to retroactively declare red lines green. Indeed, with such caveats it was difficult for me to see the RSP as much more than a declared intent to act responsibly, rather than a commitment. But the updated RSP seems to be far worse, even, than that: the “if” is no longer dependent on the outcomes of pre-specified evaluations, but on the personal judgment of Dario Amodei and Jared Kaplan.Indeed, such red lines are now mademoreimplicit and ambiguous. There are no longer predefined evaluations—instead employees design and run them on the fly, and compile the resulting evidence into a Capability Report, which is sent to the CEO for review. A CEO who, to state the obvious, is hugely incentivized to decide to deploy models, since refraining to do so might jeopardize the company.This seems strictly worse to me. Some room for flexibility is warranted, but this strikes me as almostmaximallyflexible, in that practically nothing is predefined—not evaluations, nor safeguards, nor responses to evaluations. This update makes the RSP more subjective, qualitative, and ambiguous. And if Anthropic is going to make the RSP weaker, I wish this were noted more as an apology, or along with a promise to rectify this in the future. Especially because after a year, Anthropic presumably has more information about the risk than before. Why, then, is even more flexibility needed now? Whatwouldcause Anthropic to make clear commitments?I also find it unsettling that the ASL-3 risk threshold has been substantially changed, and the reasoning for this is not explained. In the first RSP, a model was categorized as ASL-3 if it was capable of various precursors for autonomous replication. Now, this has been downgraded to a “checkpoint,” a point at which they promise to evaluate the situation more thoroughly, but don’t commit to taking any particular actions:
This strikes me as a big change. The ability to self-replicate is already concerning, but the ability to perform AI R&D seems potentially catastrophic, risking loss of control or extinction. Why does Anthropic now think this shouldn’t count as ASL-3? Why have they substituted this criteria with a substantially riskier one instead?
Dario estimates the probability of something going “really quite catastrophically wrong, on the scale of human civilization” as between 10-25%. He also thinks this might happen soon—perhaps between 2025-2027. It seems obvious to me that a policy this ambiguous, this dependent on figuring things out on the fly, this beset with such egregious conflicts of interest, is a radically insufficient means of managing risk from a technology which poses so grave and imminent a threat to our world.